載入...
The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis
Safer and more effective oral drugs are required to treat visceral leishmaniasis, a parasitic disease that kills 50-60,000 people each year. Here we report that fexinidazole, a drug currently in phase I clinical trials for treating African trypanosomiasis, shows promise for treating visceral leishma...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3457684/ https://ncbi.nlm.nih.gov/pubmed/22301556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003326 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|